OVER 20 YEARS
BACKING SOME OF THE UK’S
MOST INNOVATIVE EARLY-
STAGE COMPANIES.
BACKING
FOUNDERS
SINCE
1999
Founded in 1999, Oxford Capital offers individuals and families access to some of the most innovative early-stage companies in the UK. Over the last 20 years, we have invested approximately £500 million in over 100 companies and have pioneered investing into early-stage companies via the Enterprise Investment Scheme.
From our base in Oxford, one of the greatest knowledge clusters in the world, we invest across the UK and support early-stage companies to grow in international markets with the potential for rapid value growth. We invest in the future of UK technology in sectors such as ecommerce, fintech, digital health and Artificial Intelligence. At the heart of our approach is backing the founders of these businesses, helping turn their vision into value and delivering returns to our investors.
Recent NEWS
10 lessons we learned from co-investing in over 100 start-ups
Our long experience of investing points to the fact that Venture Capital is a team sport and building a VC syndicate is like assembling a sports team. You need members to have complimentary skills, talent and chemistry to become champions. A key feature of our …
Scan.com announces multiple partnerships
Scan.com has announced a series of partnerships to ensure more people can access the diagnostic imaging they need. They have partnered with the AA to provide accessible diagnostic imaging to their 7000 UK employees. In addition they have announced partnerships with YuLife, the tech-driven insurance …
EISA Awards shortlist
We were delighted to be shortlisted for several Enterprise Investment Scheme Association awards – the EISA Impact Award for our work with Oxford BioTherapeutics, a clinical stage oncology company focused on helping more people successfully beat cancer. Congratulations also to Scan.com – shortlisted for Best …
Sign up to our newsletter
"*" indicates required fields
BUILDING A CAREER
WITH US
Click the button below to see which roles we currently have available.